Here’s whether Edwards Lifesciences Corp (EW) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.96% over 10 days); RSI 65 — healthy momentum range; strong 1-year return of +10.5%. Currently 3.9% off its 52-week high. Score: +6/7.
EW is in a confirmed uptrend, trading above both its 50-day ($82.22) and 200-day ($81.72) moving averages. An RSI of 64.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +10.5% compares to +24.4% for SPY (trailed the market by 13.8%).
$10,000 invested 1 year ago→ $11,053 today
vs. S&P 500 (SPY) — same period trailed market by 13.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($81.72)
✓Above 50-day MA ($82.22)
✓RSI(14) neutral zone (30–70) — currently 64.8
✓Positive return (+10.5%)
✓Within 10% of period high (−3.9%)
Period Range $85.96
$72.30$89.48
RSI (14) 64.8
0 · OversoldOverbought · 100
Key Metrics
Price$85.96
Period Return+10.5%
Period High$89.48
Period Low$72.30
Drawdown−3.9%
MA-50$82.22
MA-200$81.72
RSI (14)64.8
Avg Volume (30d)5.4M
vs. SPYtrailed by 13.8%
Return Rank#611 of 1245
Trend Signals
Price is above the 200-day moving average ($81.72)